Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Larimar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LRMR.
You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.
Other companies in Larimar Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Quoin Pharmaceuticals (NASDAQ:QNRX), Korro Bio (NASDAQ:KRRO) and Fate Therapeutics (NASDAQ:FATE).
Larimar Therapeutics has a consensus price target of $19.60.
The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $1.7601 last updated April 17, 2025 at 5:48 PM EDT.
There are no upcoming dividends for Larimar Therapeutics.
Larimar Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Larimar Therapeutics.
Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.